Advances in targeted therapies by PARP inhibitors for the treatment of prostate cancer: A scientometric approach
{{output}}
Introduction: The most prevalent cancer in men is prostate cancer (PCa). One significant discovery involves attacking tumors with mutations in DNA damage repair genes via the blockage of poly(ADP-ribose) polymerase (PARP) enzymes... ...
